Ono Pharmaceutical , Ltd. Profit Margin

The latest profit margin for OPHLY is 15.11% as of June 2026. That compares with 8.64% in the prior-year period — up 74.9% year over year. That is above the sector sector average of 13.16%. Investors often review this figure alongside Ono Pharmaceutical , Ltd.'s historical trend and sector peers before judging valuation or financial health.

Over the past year, OPHLY's profit margin moved from 8.64% to 15.11% — a 74.9% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Ono Pharmaceutical , Ltd.'s valuation or profitability profile.

Against its sector companies, OPHLY currently prints 15.11% for profit margin, while the sector average sits near 13.16%. That is roughly 14.8% above the sector mean. Large gaps often invite a closer look at Ono Pharmaceutical , Ltd.'s growth, margins, and balance sheet.

Profit Margin shows how effectively Ono Pharmaceutical , Ltd. converts resources into returns. At 15.11%, OPHLY may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with 8.64% in the prior-year period — up 74.9% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.

After noting OPHLY's profit margin (15.11%), review year-over-year change from 8.64%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.